##gff-version 3
##sequence-region Q7Z5L9 1 587
Q7Z5L9	UniProtKB	Initiator methionine	1	1	.	.	.	Note=Removed;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22814378;Dbxref=PMID:19413330,PMID:22814378	
Q7Z5L9	UniProtKB	Chain	2	587	.	.	.	ID=PRO_0000328734;Note=Interferon regulatory factor 2-binding protein 2	
Q7Z5L9	UniProtKB	Zinc finger	506	553	.	.	.	Note=RING-type%3B degenerate	
Q7Z5L9	UniProtKB	Region	506	550	.	.	.	Note=Cys-rich	
Q7Z5L9	UniProtKB	Motif	354	361	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:21887377;Dbxref=PMID:21887377	
Q7Z5L9	UniProtKB	Compositional bias	104	200	.	.	.	Note=Pro-rich	
Q7Z5L9	UniProtKB	Modified residue	2	2	.	.	.	Note=N-acetylalanine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19413330,ECO:0000244|PubMed:22814378;Dbxref=PMID:19413330,PMID:22814378	
Q7Z5L9	UniProtKB	Modified residue	71	71	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q7Z5L9	UniProtKB	Modified residue	175	175	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:24275569;Dbxref=PMID:17081983,PMID:20068231,PMID:24275569	
Q7Z5L9	UniProtKB	Modified residue	240	240	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:E9Q1P8	
Q7Z5L9	UniProtKB	Modified residue	318	318	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:24275569;Dbxref=PMID:24275569	
Q7Z5L9	UniProtKB	Modified residue	360	360	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000269;evidence=ECO:0000244|PubMed:17081983,ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:23186163,ECO:0000269|PubMed:21887377;Dbxref=PMID:17081983,PMID:19690332,PMID:20068231,PMID:23186163,PMID:21887377	
Q7Z5L9	UniProtKB	Modified residue	406	406	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:E9Q1P8	
Q7Z5L9	UniProtKB	Modified residue	423	423	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:E9Q1P8	
Q7Z5L9	UniProtKB	Modified residue	455	455	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q7Z5L9	UniProtKB	Modified residue	457	457	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163	
Q7Z5L9	UniProtKB	Modified residue	460	460	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231,ECO:0000244|PubMed:21406692,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:20068231,PMID:21406692,PMID:23186163	
Q7Z5L9	UniProtKB	Cross-link	289	289	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q7Z5L9	UniProtKB	Cross-link	303	303	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q7Z5L9	UniProtKB	Cross-link	324	324	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q7Z5L9	UniProtKB	Cross-link	326	326	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q7Z5L9	UniProtKB	Cross-link	348	348	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2);Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:28112733;Dbxref=PMID:28112733	
Q7Z5L9	UniProtKB	Alternative sequence	1	424	.	.	.	ID=VSP_032769;Note=In isoform 3. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q7Z5L9	UniProtKB	Alternative sequence	333	348	.	.	.	ID=VSP_032770;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:12799427;Dbxref=PMID:12799427	
Q7Z5L9	UniProtKB	Natural variant	254	254	.	.	.	ID=VAR_042503;Note=A->V;Dbxref=dbSNP:rs11502	
Q7Z5L9	UniProtKB	Natural variant	551	551	.	.	.	ID=VAR_080578;Note=In CVID14%3B increased protein abundance in patient-derived B lymphocytes%3B impairs immature B cell differentiation. S->N;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:27016798;Dbxref=PMID:27016798	
Q7Z5L9	UniProtKB	Sequence conflict	177	177	.	.	.	Note=N->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z5L9	UniProtKB	Sequence conflict	177	177	.	.	.	Note=N->K;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z5L9	UniProtKB	Sequence conflict	183	183	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z5L9	UniProtKB	Sequence conflict	183	183	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z5L9	UniProtKB	Sequence conflict	246	246	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q7Z5L9	UniProtKB	Sequence conflict	246	246	.	.	.	Note=A->T;Ontology_term=ECO:0000305;evidence=ECO:0000305	
